Loading
institutionsInstitution
Keio University Hospital
Tokyo's oldest private university hospital, known for gastrointestinal and oesophageal cancer surgery, cancer genome profiling and translational research.
Also called: 慶應義塾大学病院
Overview
Keio University Hospital, opened in 1920, is one of Japan's core hospitals for cancer genome medicine and a leader in gastrointestinal cancer surgery: Yuko Kitagawa's department is a JCOG oesophageal cancer study group leader and pioneered sentinel node navigation surgery in the upper GI tract. Keio's Cancer Center integrates the PleSSision genomic profiling programme, one of the first hospital-based comprehensive genomic tests in Japan, with molecular tumour boards, and Keio researchers have contributed to organoid biobanks of colorectal cancer, haematological malignancy research and cancer immunology. Patients can access early-phase trials, robotic surgery and precision oncology through the Keio Cancer Center.
Location
Tokyo, JP
Type
hospital · Keio University
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#307 · 22 points (0 Newsweek + 0 NCI + 22 from 11 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-15.
Matched to Keio University Hospital, including child institutions. 139 works · 708 citations · 60% open access · 6% clinical trials · 3% reviews.
Oncology works per year
332022
322023
232024
322025
192026
Most works
- Kengo Nagashima24 works
- Yuko Kitagawa16 works
- Hisakazu Ohtani13 works
- Ayuko Imaoka11 works
- Takeshi Akiyoshi11 works
- Hiroshi Nishihara9 works
- Kenro Hirata8 works
- Minoru Kitago7 works
- Koji Okabayashi7 works
- Ryo Seishima7 works
Most cited
- Oesophageal and gastric surgery (JCOG)
- Cancer genome profiling (PleSSision)
- Colorectal organoids
- Haematology
Koichi Fukunaga
Director General
Respiratory medicineHospital leadershipLung disease
Respiratory physician who heads Keio University Hospital in Tokyo, a leading Japanese academic hospital with designated cancer centre status.
Yuko Kitagawa
Professor of Surgery, Keio University; oesophageal surgery; JCOG oesophageal group leadership
Oesophageal cancer surgeryPerioperative therapySentinel node navigation
Yuko Kitagawa is a leading oesophageal surgeon in the JCOG network, whose trials define perioperative treatment for oesophageal cancer in Japan.
Similar pages
- InstitutionKyushu University Hospital
Shares Japan Clinical Oncology Group (JCOG), Robotic & minimally invasive surgery, Comprehensive genomic profiling, Oesophageal cancer.
- InstitutionOsaka International Cancer Institute
Shares Japan Clinical Oncology Group (JCOG), Robotic & minimally invasive surgery, Comprehensive genomic profiling, Oesophageal cancer.
- InstitutionAichi Cancer Center
Shares Japan Clinical Oncology Group (JCOG), Comprehensive genomic profiling, Oesophageal cancer, Gastric & gastro-oesophageal junction cancer.
- PersonHaruhiko Fukuda
Shares Japan Clinical Oncology Group (JCOG), Oesophageal cancer, Gastric & gastro-oesophageal junction cancer.
- IdeaA permanently funded international network for randomised cancer surgery trials
Shares Yuko Kitagawa, Japan Clinical Oncology Group (JCOG), Sentinel lymph node biopsy, Robotic & minimally invasive surgery.
- CollectionJapanese oncology guidelines (JSMO, JSCO and organ societies)
Shares Japan Clinical Oncology Group (JCOG), Comprehensive genomic profiling, Oesophageal cancer, Gastric & gastro-oesophageal junction cancer.
- InstitutionNational Cancer Center Hospital East
Shares Japan Clinical Oncology Group (JCOG), Comprehensive genomic profiling, Oesophageal cancer, Gastric & gastro-oesophageal junction cancer.
- InstitutionShizuoka Cancer Center
Shares Japan Clinical Oncology Group (JCOG), Gastric & gastro-oesophageal junction cancer, Colorectal cancer.